PHOENIX, Aug. 4, 2023 /PRNewswire/ – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”), a vertically integrated, multi-state cannabis operator and retailer, today announced that Keith Adams, Chief Financial Officer, has ended his tenure with the Company…
Month: August 2023
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Futu Holdings Limited (“Futu” or the “Company”) (NASDAQ: FUTU). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
MONTREAL, Aug. 4, 2023 /PRNewswire/ – The Lion Electric Company (NYSE: LEV) (TSX: LEV) (“Lion” or the “Company”), a leading manufacturer of all-electric medium and heavy-duty urban vehicles, announced today that the Company will be presenting at the following investor conference in…
SILVER SPRING, Md., Aug. 4, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a new guidance for immediate implementation, “Recommended Acceptable Intake Limits for Nitrosamine Drug…
METAIRIE, La., Aug. 4, 2023 /PRNewswire/ — Eureka Homestead Bancorp, Inc. (“the “Company”) (OTC Pink Marketplace: “ERKH”), the holding company of Eureka Homestead, a federal savings association headquartered in Metairie, Louisiana, and Eureka Investor Group, Inc. have reached an…
Conference Call and Webcast on August 7, 2023 LAKEWOOD, Colo., Aug. 4, 2023 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (“Energy Fuels” or the “Company”) today reported its financial results for the quarter ended June 30, 2023. The Company’s Quarterly Report on Form…
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mesoblast Limited (“Mesoblast” or the “Company”) (NASDAQ: MESO). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
TORONTO, Aug. 4, 2023 /PRNewswire/ – In accordance with Toronto Stock Exchange requirements, Canaccord Genuity Group Inc. (TSX: CF) (the “Company”) announces the voting results from its annual general meeting of common shareholders held on Friday August 4, 2023. Full details of these…
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Syneos Health, Inc. (“Syneos” or the “Company”) (NASDAQ: SYNH). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…